ReviewJournal of the International AIDS Society2018
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
Review in Journal of the International AIDS Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 40 citations in OpenAlex.
- Social-ecological predictors of HIV testing among adult men: analysis of the 2022 Tanzania demographic and health survey data.BMJ global health · 2025Article
- Optimizing health resource allocation for improving timely HIV diagnosis in China.Journal of the International AIDS Society · 2024Article
- A quantitative assessment of the consistency of projections from five mathematical models of the HIV epidemic in South Africa: a model comparison study.BMC public health · 2023Article
- Assessing potential insights of an imperfect testing strategy: Parameter estimation and practical identifiability using early COVID-19 data in India.Communications in nonlinear science & numerical simulation · 2023Article
- How to do (or not to do)… health resource allocations using constrained mathematical optimization.Health policy and planning · 2023Article
- Approaches to improving the efficiency of HIV programme investments.BMJ global health · 2022Article
- A qualitative model of the HIV care continuum in Vancouver, Canada.Health systems (Basingstoke, England) · 2022Article
- Technical efficiency of national HIV/AIDS spending in 78 countries between 2010 and 2018: A data envelopment analysis.PLOS global public health · 2022Article
- Optima TB: A tool to help optimally allocate tuberculosis spending.PLoS computational biology · 2021Article
- Testing, tracing and isolation in compartmental models.PLoS computational biology · 2021Article
- Diabetes care cascade in Ukraine: an analysis of breakpoints and opportunities for improved diabetes outcomes.BMC health services research · 2020Article
- Article
- Optimal allocation of HIV resources among geographical regions.BMC public health · 2019Article
- Evolving HIV epidemics: the urgent need to refocus on populations with risk.Current opinion in HIV and AIDS · 2019Review
- Measuring financial risk protection in health benefits packages: scoping review protocol to inform allocative efficiency studies.BMJ open · 2019Article
- HIV, 95-95-95 and the allocative efficiency fallacy: why treating everyone makes sense from a humanitarian, clinical, economic and disease control perspective.Journal of the International AIDS Society · 2018Article
- "Optima attempts to objectively and pragmatically assist countries meet their targets most efficiently and effectively".Journal of the International AIDS Society · 2018Article
- How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.Journal of the International AIDS Society · 2018Review
- The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there.Journal of the International AIDS Society · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 9 institutions in 5 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionWith limited funds available, meeting global health targets requires countries to both mobilize and prioritize their health spending. Within this context, countries have recognized the importance of allocating funds for HIV as efficiently as possible to maximize impact. Over the past six years, the governments of 23 countries in Africa, Asia, Eastern Europe and Latin America have used the Optima HIV tool to estimate the optimal allocation of HIV resources.
methodsEach study commenced with a request by the national government for technical assistance in conducting an HIV allocative efficiency study using Optima HIV. Each study team validated the required data, calibrated the Optima HIV epidemic model to produce HIV epidemic projections, agreed on cost functions for interventions, and used the model to calculate the optimal allocation of available funds to best address national strategic plan targets. From a review and analysis of these 23 country studies, we extract common themes around the optimal allocation of HIV funding in different epidemiological contexts. RESULTS AND DISCUSSION: The optimal distribution of HIV resources depends on the amount of funding available and the characteristics of each country's epidemic, response and targets. Universally, the modelling results indicated that scaling up treatment coverage is an efficient use of resources. There is scope for efficiency gains by targeting the HIV response towards the populations and geographical regions where HIV incidence is highest. Across a range of countries, the model results indicate that a more efficient allocation of HIV resources could reduce cumulative new HIV infections by an average of 18% over the years to 2020 and 25% over the years to 2030, along with an approximately 25% reduction in deaths for both timelines. However, in most countries this would still not be sufficient to meet the targets of the national strategic plan, with modelling results indicating that budget increases of up to 185% would be required.
conclusionsGreater epidemiological impact would be possible through better targeting of existing resources, but additional resources would still be required to meet targets. Allocative efficiency models have proven valuable in improving the HIV planning and budgeting process.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.